Elon Musk's start-up Neuralink says it has gotten approval from U.S. regulators to test its brain implants in people.

Axar.az reports that Neuralink said clearance from the U.S. Food and Drug Administration (FDA) for its first-in-human clinical study is "an important first step" for its technology, which is intended to let brains interface directly with computers.

"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Musk-run Twitter. "This is the result of incredible work by the Neuralink team in close collaboration with the FDA."

Recruitment for a clinical trial is not yet open, according to Neuralink.

The aim of Neuralink implants is to enable human brains to communicate directly with computers, Musk said during a presentation by the start-up in December.